NBTY Moves On From U.K. Health Food Retail Misadventure
This article was originally published in The Tan Sheet
Less than four years after acquiring U.K. chain Julian Graves as a platform for European growth, NBTY absorbs a $20 mil. charge to get rid of the subsidiary, which had “continuing operating losses.” NBTY plans to refocus resources on Holland & Barrett and its other European supplement retailers.
You may also be interested in...
Schiff Nutrition CEO Tarang Amin, a veteran of managing brands for Clorox and P&G, sees additional upside in top-selling brands such as MegaRed and Move Free. The firm also is de-emphasizing its struggling private label business.
NBTY prioritizes development of sports nutrition products and wants to broaden the category as it increases its focus on branded sales due to competitive pressure in the private label space.
NBTY's acquisition of private label nutritionals manufacturer Vitarich Laboratories allows the firm to expand its in-house production of liquid nutritional products and builds its presence in the category.